D-0969-2015 Class I Terminated
FDA drug recall D-0969-2015 was initiated by Hospira Inc. on Jan 20, 2015 and is designated Class I. Reason for recall: Presence of Particulate Matter; Hospira has identified the particulate as a human hair, sealed in the bag at the additive port area. The recall status is terminated (terminated Jan 17, 2017). Affected quantity: 661,128 containers.
Recall Details
- Product Type
- Drugs
- Report Date
- Apr 29, 2015
- Initiation Date
- Jan 20, 2015
- Termination Date
- Jan 17, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 661,128 containers
Product Description
0.9% Sodium Chloride Injection, USP, 250 mL, Rx Only, Hospira Inc., Lake Forest, IL, 60045, USA, NDC 0409-7983-02
Reason for Recall
Presence of Particulate Matter; Hospira has identified the particulate as a human hair, sealed in the bag at the additive port area.
Distribution Pattern
Nationwide
Code Information
Lot #: 44-002-JT (the lot number may be followed by 01 to 99), Exp 08/01/2016
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0969-2015
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026